Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Breast Neoplasms and PPARGC1B[original query] |
---|
Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis 2006 Nov 27 (11): 2201-8. Wirtenberger Michael, Tchatchou Sandrine, Hemminki Kari, Schmutzhard Julia, Sutter Christian, Schmutzler Rita K, Meindl Alfons, Wappenschmidt Barbara, Kiechle Marion, Arnold Norbert, Weber Bernhard H F, Niederacher Dieter, Bartram Claus R, Burwinkel Barba |
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. Breast cancer research : BCR 2011 13 (1): R10. Li Yuqing, Li Yi, Wedrén Sara, Li Guoliang, Charn Tze Howe, Desai Kartiki Vasant, Bonnard Carine, Czene Kamila, Humphreys Keith, Darabi Hatef, Einarsdóttir Kristjana, Heikkinen Tuomas, Aittomäki Kristiina, Blomqvist Carl, Chia Kee Seng, Nevanlinna Heli, Hall Per, Liu Edison T, Liu Jianj |
PPAR? and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2013 Sep 18 (6): 493-501. Martínez-Nava Gabriela A, Burguete-García Ana I, López-Carrillo Lizbeth, Hernández-Ramírez Raúl U, Madrid-Marina Vicente, Cebrián Mariano |
Genetic polymorphisms of PPAR gamma, arsenic methylation capacity and breast cancer risk in Mexican women. Salud publica de Mexico 2016 Apr 58 (2): 220-7. Pineda-Belmontes Cristina P, Hernández-Ramírez Raúl U, Hernández-Alcaraz César, Cebrián Mariano E, López-Carrillo Lizbe |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: